- Home
- RNAC vs EHAB Comparison
RNAC vs EHAB Comparison
Compare RNAC & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- EHAB
- Stock Information
- Founded
- RNAC 2007
- EHAB 2014
- Country
- RNAC United States
- EHAB United States
- Employees
- RNAC N/A
- EHAB N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- EHAB Hospital/Nursing Management
- Sector
- RNAC Health Care
- EHAB Health Care
- Exchange
- RNAC Nasdaq
- EHAB Nasdaq
- Market Cap
- RNAC 415.8M
- EHAB 401.8M
- IPO Year
- RNAC 2016
- EHAB N/A
- Fundamental
- Price
- RNAC $14.54
- EHAB $8.65
- Analyst Decision
- RNAC Strong Buy
- EHAB Hold
- Analyst Count
- RNAC 8
- EHAB 3
- Target Price
- RNAC $40.83
- EHAB $8.50
- AVG Volume (30 Days)
- RNAC 98.4K
- EHAB 427.9K
- Earning Date
- RNAC 05-07-2025
- EHAB 03-05-2025
- Dividend Yield
- RNAC N/A
- EHAB N/A
- EPS Growth
- RNAC N/A
- EHAB N/A
- EPS
- RNAC N/A
- EHAB N/A
- Revenue
- RNAC $38,913,000.00
- EHAB $1,034,800,000.00
- Revenue This Year
- RNAC N/A
- EHAB $5.72
- Revenue Next Year
- RNAC $60.00
- EHAB $4.75
- P/E Ratio
- RNAC N/A
- EHAB N/A
- Revenue Growth
- RNAC 49.64
- EHAB N/A
- 52 Week Low
- RNAC $11.67
- EHAB $6.85
- 52 Week High
- RNAC $41.87
- EHAB $11.69
- Technical
- Relative Strength Index (RSI)
- RNAC 33.21
- EHAB 48.82
- Support Level
- RNAC $13.57
- EHAB $8.71
- Resistance Level
- RNAC $16.79
- EHAB $9.00
- Average True Range (ATR)
- RNAC 1.21
- EHAB 0.35
- MACD
- RNAC -0.13
- EHAB -0.02
- Stochastic Oscillator
- RNAC 18.55
- EHAB 41.20
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.